Although I respect your opinion, unfortunately it is not "end of story". Amarin needs the FDA granted label expansion for better insurance coverage, thus allowing doctors to more easily prescribe and more affordable to the patient.
“FDA approval is a formality”....no, FDA approval for expanded label Is a necessity! Tight ass insurance providers will be a problem until FDA approval. As for script...haven’t seen much improvement post AHA. Hope that changes
News 
Market Data 
Discover 
